| 000 | 01192 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512195021.0 | ||
| 264 | 0 | _c19801021 | |
| 008 | 198010s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1980.tb05849.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiley, A J | |
| 245 | 0 | 0 |
_aSome further evidence for partial agonist activity of labetalol. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cMay 1980 |
||
| 300 |
_a517-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdrenergic Agonists |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEthanolamines _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xpharmacology |
| 650 | 0 | 4 |
_aLabetalol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 | _aPlacebos |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 9 _gno. 5 _gp. 517-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1980.tb05849.x _zAvailable from publisher's website |
| 999 |
_c6105070 _d6105070 |
||